UK markets open in 3 hours 13 minutes

Zealand Pharma A/S (22ZA.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
17.100.00 (0.00%)
At close: 08:02AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in DKK. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
344,249
342,788
103,986
108,546
192,001
-
Cost of revenue
23,771
19,174
0
10,970
0
-
Gross profit
320,478
323,614
103,986
97,576
192,001
-
Operating expenses
Research development
733,575
684,902
614,044
581,511
595,847
-
Selling general and administrative
118,145
89,849
306,541
298,209
222,389
-
Total operating expenses
984,861
900,831
920,585
879,720
818,236
-
Operating income or loss
-664,383
-577,217
-816,599
-782,144
-626,235
-
Interest expense
18,480
24,888
56,455
4,091
2,895
-
Total other income/expenses net
-
-
-
30,777
-4,068
9,242
Income before tax
-743,541
-708,865
-972,041
-758,887
-673,527
-
Income tax expense
-4,787
-5,126
-6,431
-3,949
-4,814
-
Income from continuing operations
-738,754
-703,739
-965,610
-754,938
-668,713
-
Net income
-738,754
-703,739
-1,202,135
-1,018,149
-846,729
-
Net income available to common shareholders
-738,754
-703,739
-1,202,135
-1,018,149
-846,729
-
Basic EPS
-
-
-
-23.75
-22.07
-16.91
Diluted EPS
-
-
-
-23.75
-22.07
-16.91
Basic average shares
-
-
-
42,869
38,370
33,802
Diluted average shares
-
-
-
42,869
38,370
33,802